ProQR Therapeutics N.V.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving ProQR Therapeutics N.V. now
Current reporting with the operating signal separated from the noise.
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 92.5% in July
The story matters when it changes ProQR Therapeutics N.V.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.[SCHEDULE 13D/A] ProQR Therapeutics N.V. Amended Major Shareholder Report
Investors are testing whether ProQR Therapeutics N.V.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Proqr Therapeutics N.v. (PRQR)
The story matters when it changes ProQR Therapeutics N.V.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript
The story matters when it changes ProQR Therapeutics N.V.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.ProQR Therapeutics N.V. (PRQR) Presents at Evercore 8th Annual Healthcare Conference Transcript
The story matters when it changes ProQR Therapeutics N.V.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Chardan Capital Maintains ProQR Therapeutics N.V. (PRQR) Buy Recommendation
The development tests whether ProQR Therapeutics N.V. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Chardan Capital Upgrades ProQR Therapeutics N.V (PRQR)
The story matters when it changes ProQR Therapeutics N.V.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.ProQR Therapeutics N.V.
The story matters when it changes ProQR Therapeutics N.V.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest PRQR filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
ProQR Therapeutics N.V., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →